血管生成抑制剂内皮抑素中的D104N多态性与急性和慢性髓性白血病 - Suppr | 超能文献

D104N polymorphism in endostatin, an angiogenesis inhibitor, in acute and chronic myeloid leukaemia.

作者信息

Nascimento Helvia, Lourenço Gustavo J, Ortega Manoela M, Yamaguti Gabriela G, Costa Fernando F, Lima Carmen S P

出版信息

Leuk Res. 2007 Aug;31(8):1158-9. doi: 10.1016/j.leukres.2006.09.019. Epub 2006 Oct 25.

DOI:10.1016/j.leukres.2006.09.019

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

D104N polymorphism in endostatin, an angiogenesis inhibitor, in acute and chronic myeloid leukaemia.血管生成抑制剂内皮抑素中的D104N多态性与急性和慢性髓性白血病

Leuk Res. 2007 Aug;31(8):1158-9. doi: 10.1016/j.leukres.2006.09.019. Epub 2006 Oct 25.

2

MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea.MTHFR 677CC/1298CC基因型与慢性粒细胞白血病高度相关：韩国的一项病例对照研究。

Leuk Res. 2007 Sep;31(9):1213-7. doi: 10.1016/j.leukres.2006.10.016. Epub 2006 Dec 6.

3

Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study.血管生成抑制剂内皮抑素的多态性与前列腺癌风险及生存：一项前瞻性研究。

Int J Cancer. 2009 Sep 1;125(5):1143-6. doi: 10.1002/ijc.24423.

4

Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia.慢性髓性白血病中谷胱甘肽S-转移酶μ1（GSTM1）和θ1（GSTT1）基因的多态性

Eur J Haematol. 2005 Dec;75(6):530-1. doi: 10.1111/j.1600-0609.2005.00567.x.

5

A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.内皮抑素是一种血管生成抑制剂，其基因多态性易引发前列腺腺癌。

Cancer Res. 2001 Oct 15;61(20):7375-8.

6

Antiangiogenic gene therapy of myeloproliferative disease developed in transgenic mice expressing P230 bcr/abl.在表达P230 bcr/abl的转基因小鼠中开展的骨髓增殖性疾病抗血管生成基因治疗。

Gene Ther. 2005 Mar;12(6):541-5. doi: 10.1038/sj.gt.3302427.

7

[GPI-PLD gene exon14 polymorphisms of leucocyte in peripheral blood from healthy persons and leukemia patients].[健康人和白血病患者外周血白细胞中糖基磷脂酰肌醇特异性磷脂酶D基因外显子14多态性]

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Feb;31(1):28-31.

8

TP53 codon 72 polymorphism in patients with chronic myeloid leukemia.慢性髓性白血病患者中TP53基因第72位密码子的多态性

Haematologica. 2004 Jul;89(7):868-9.

9

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.杀伤细胞免疫球蛋白样受体（KIR2DL2和/或KIR2DS2）在其配体（HLA - C1组）存在的情况下可预防慢性髓性白血病。

Tissue Antigens. 2009 Jun;73(6):553-60. doi: 10.1111/j.1399-0039.2009.01235.x.

10

Rare translocations involving chromosome band 8p11 in myeloid neoplasms.髓系肿瘤中涉及染色体带8p11的罕见易位。

Cancer Genet Cytogenet. 2008 Oct 15;186(2):127-9. doi: 10.1016/j.cancergencyto.2008.07.002.

引用本文的文献

1

Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells.转谷氨酰胺酶 2：内皮细胞细胞外基质中的一个新的内皮抑素伴侣。

Biochem J. 2010 Apr 14;427(3):467-75. doi: 10.1042/BJ20091594.

2

Molecular interplay between endostatin, integrins, and heparan sulfate.内皮抑素、整合素与硫酸乙酰肝素之间的分子相互作用。

J Biol Chem. 2009 Aug 14;284(33):22029-22040. doi: 10.1074/jbc.M109.002840. Epub 2009 Jun 5.